This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Lynparza
  • /
  • OSCA - Olaparib Standard of CAre Study
Clinical trial

OSCA - Olaparib Standard of CAre Study

Read time: 1 mins
Last updated:5th Oct 2014

This study will be carried out as a retrospective, non-interventional observational review of medical records for patients in multiple countries with platinum-sensitive recurrent serous ovarian cancer. The objectives are to describe in a real-world population, treatment patterns, BRCA mutation testing and results, overall survival, health care utilization and also to estimate rates of selected treatment- and/or disease-related side effects.

Study Type: Observational
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Real-World Treatment Patterns, BRCA Testing Practices, Outcomes, and Health Care Utilization in Platinum-Sensitive Recurrent Serous Ovarian Cancer: A Multi-Country Retrospective Study
Estimated Enrollment: 2000
Study Start Date: October 2014
Estimated Study Completion Date: May 2015
Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)

Category Value
Study start date 2014-10-06

View full details